Delivery Order SPE2DB22D3016-SPE2DB24FAVE4
Award Date
5/10/24
Potential Completion Date
5/13/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,433.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tizanidine HCl 4 mg tablets in quantities of 1,000. The contract is a Firm Fixed Price (FFP) Delivery Order, with an ultimate completion date of July 1, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,733.50, is for the delivery of tizanidine HCl 4 mg tablets in 1,000-count bottles. The contract is a firm fixed-price delivery order with a performance period through March 26, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,401.40 firm fixed-price delivery order is for the supply of 4,567,212 units of the medication tizanidine hydrochloride 2 mg tablets. The contract has an ultimate completion date of February 11, 2025 and was awarded on February 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a $1,051.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,351,718 units of the generic drug tizanidine hydrochloride 4 mg capsules. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $12,568.59 firm-fixed-price delivery order is for the supply of 4,565,838 units of Tizanidine HCl 4 mg tablets. The contract has an ultimate completion date of September 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) to provide a wide range of...
This federal contract award, valued at $5,000.94, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567074252 - Tizanidine HCL 4 mg Tablets in quantities of 1000s. The contract has an ultimate completion date of January 29, 2025 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $5,489.63, is for the delivery of 4 mg tizanidine hydrochloride tablets in 1,000-count quantities. The contract has a completion date of February 21, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,490.84, is a Firm Fixed Price Delivery Order for the supply of 4 mg Tizanidine HCL tablets. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, SPE2DX15D3014|SPE2DX23FUBXJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,125.09 firm fixed-price delivery order is for the supply of 4 mg tizanidine hydrochloride tablets. This award is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,415.60 firm fixed-price delivery order is for the supply of 4 mg tizanidine hydrochloride tablets, a medication used for muscle spasticity. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a vehicle for...